Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyD. Ross Camidge, Alice T. Shaw, Ravi Salgia et al.|The Lancet Oncology|2012Cited by 1.3k
131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M. Pagel, Dana C. Matthews, Frederick R. Appelbaum et al.|Blood|2005Cited by 157
131I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).John M. Pagel, Rainer Storb, Frederick R. Appelbaum et al.|Blood|2005Cited by 25
131I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.John M. Pagel, Dana C. Matthews, Frederick R. Appelbaum et al.|Blood|2004Cited by 8
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA IN FIRST REMISSIONJohn M. Pagel, Dana C. Matthews, Frederick R. Appelbaum et al.|Unknown|2013Cited by 0